MTVA MetaVia Inc.

P/E --
Forward P/E --
Price/Sales --
Beta 0.585
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ MetaVia Inc. is trading 6% down today after clinical data on its obesity drug candidate

MetaVia Inc. is trading approximately 6% down at $2.42 in after-hours trading as investors digest clinical data for its dual GLP-1/glucagon candidate,...

MetaVia Surges on New Obesity and Diabetes Drug Data

MetaVia Surges on New Obesity and Diabetes Drug Data

MetaVia Inc. (MTVA) shares rose following the presentation of new clinical data at the American Diabetes Association’s (ADA) 2026 Scientific Sessions. The...

🟒 MetaVia Inc. is trading 10.6% up today on ADA 2026 abstract acceptance for obesity pipeline

MetaVia Inc. is trading 10.6% up at $2.71 following news that three late-breaking posters were accepted for presentation at the American Diabetes Association...

MetaVia Surges 34% in a Single Session, but Can a Micro-Cap Biotech With Dilution Risk Sustain This Bounce?

MetaVia Surges 34% in a Single Session, but Can a Micro-Cap Biotech With Dilution Risk Sustain This Bounce?

Shares of MetaVia Inc. (MTVA) rocketed 33.9% to $3.28 on June 5, clawing back nearly all of a week-long slide that had dragged the stock from $2.84 to $2.45 β€”...

🟒 MetaVia Inc. is trading 34% up today on obesity pipeline focus and financing updates

MetaVia Inc. is trading 34% up at $3.28 in pre-market, sharply rebounding from a week-long slide that saw shares close at $2.45 on June 04, 2026. β€’ The move...

πŸ”΄ MetaVia Inc. falls 4.1% as investors weigh financing risks ahead of key conference and shareholder vote

MetaVia Inc. is trading 4.1% down at $2.57, continuing a sharp pullback from a late-May rally as investors assess financing and listing risks ahead of key...

πŸ”΄ MetaVia Inc. is trading 6.3% down today with no clear company-specific catalyst

MetaVia Inc. is trading at $2.51 (6.3% down) amid continued weakness and a lack of fresh company-specific headlines or filings. β€’ The move follows recent...

πŸ”΄ MetaVia Inc. is trading 11.36% down today on continued speculative profit-taking following ADA 2026 momentum

MetaVia Inc. is trading at $2.42 (-11.36%) today following a sharp selloff and continued speculative profit-taking. β€’ The recent weakness is tied to prior...

πŸ”΄ MTVA is trading 5.3% down today on continued speculative profit-taking

MTVA is trading at $2.69 (5.3% down) in pre-market, extending a trend of sharp swings and profit-taking-driven pullbacks. β€’ The decline follows a 7.9% drop on...

πŸ”΄ MTVA is trading 7.9% down today on speculative profit-taking following recent volatility

MTVA is trading 7.9% down today at $2.85 as the stock pulls back from a sharp multi-day rally driven by speculative trading and profit-taking. β€’ The move...

πŸ”΄ MTVA is trading 5.5% down today amid speculative profit-taking

MTVA is trading 5.5% down at $2.93 amid speculative profit-taking following a week of extreme volatility. β€’ The stock has experienced multiple double-digit...